"Since the CVS investor day in December of last year, investors have been waiting for details on how the company plans to deploy capital in order to improve its care delivery model," says BofA Global Research analyst Michael Cherny, who has a Buy rating on CVS. CVS plans to submit an offer for SGFY in the coming week, the article indicates, citing people familiar with the matter.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |